First Manhattan

First Manhattan Portfolio holdings

AUM $35.4B
1-Year Return 24.51%
This Quarter Return
+8.37%
1 Year Return
+24.51%
3 Year Return
+86.41%
5 Year Return
+172.47%
10 Year Return
+337.52%
AUM
$23.2B
AUM Growth
+$2.3B
Cap. Flow
+$754M
Cap. Flow %
3.25%
Top 10 Hldgs %
51.66%
Holding
1,610
New
206
Increased
236
Reduced
402
Closed
82

Sector Composition

1 Financials 37.83%
2 Technology 15.62%
3 Healthcare 11%
4 Consumer Discretionary 9.69%
5 Communication Services 9.12%
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
GES icon
1501
Guess, Inc.
GES
$878M
$0 ﹤0.01%
11
GPRO icon
1502
GoPro
GPRO
$236M
$0 ﹤0.01%
11
GRVY
1503
GRAVITY
GRVY
$444M
-50
Closed -$9K
GSAT icon
1504
Globalstar
GSAT
$3.96B
$0 ﹤0.01%
12
HI icon
1505
Hillenbrand
HI
$1.85B
-100
Closed -$3K
HPP
1506
Hudson Pacific Properties
HPP
$1.16B
-36
Closed
HRTX icon
1507
Heron Therapeutics
HRTX
$201M
-40
Closed
HST icon
1508
Host Hotels & Resorts
HST
$12B
-96
Closed -$1K
IDYA icon
1509
IDEAYA Biosciences
IDYA
$2.38B
-296
Closed -$4K
IEV icon
1510
iShares Europe ETF
IEV
$2.32B
-2,000
Closed -$95K
IGIB icon
1511
iShares 5-10 Year Investment Grade Corporate Bond ETF
IGIB
$16.3B
-96
Closed -$5K
INSM icon
1512
Insmed
INSM
$30.7B
$0 ﹤0.01%
25
IRT icon
1513
Independence Realty Trust
IRT
$4.22B
$0 ﹤0.01%
65
IWP icon
1514
iShares Russell Mid-Cap Growth ETF
IWP
$20.4B
-80
Closed -$8K
IXUS icon
1515
iShares Core MSCI Total International Stock ETF
IXUS
$48.1B
-524
Closed -$35K
JAZZ icon
1516
Jazz Pharmaceuticals
JAZZ
$7.86B
-120
Closed -$19K
JMIA
1517
Jumia Technologies
JMIA
$1.09B
-100
Closed -$4K
KIO
1518
KKR Income Opportunities Fund
KIO
$514M
$0 ﹤0.01%
15
KN icon
1519
Knowles
KN
$1.85B
$0 ﹤0.01%
10
LC icon
1520
LendingClub
LC
$1.9B
$0 ﹤0.01%
26
-132
-84%
LCTX icon
1521
Lineage Cell Therapeutics
LCTX
$279M
$0 ﹤0.01%
94
LDTCW
1522
DELISTED
LeddarTech Holdings Inc. Warrants
LDTCW
$0 ﹤0.01%
+200
New
LE icon
1523
Lands' End
LE
$439M
$0 ﹤0.01%
35
LIND icon
1524
Lindblad Expeditions
LIND
$803M
-500
Closed -$8K
LRCX icon
1525
Lam Research
LRCX
$130B
0